Valuation: aap Implantate AG

Market Cap 21.56M 24.66M 19.94M 18.3M 34.63M 2.38B 35.23M 238M 93.41M 1.16B 92.63M 90.59M 4.01B P/E 2024
-3.6x
P/E 2025 -7.58x
Enterprise Value 21.25M 24.31M 19.65M 18.03M 34.12M 2.34B 34.72M 234M 92.05M 1.14B 91.28M 89.27M 3.95B EV / Sales 2024
1.31x
EV / Sales 2025 1.52x
Free-Float
38.21%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 64 2019-04-30
Director TitleAgeSince
Director/Board Member 70 2015-12-31
Chairman 54 2019-07-03
Director/Board Member 50 2021-10-31
Change 5-day change 1-year change 3-year change Capi.($)
-9.59%-5.71% - - 25.3M
+10.71%+4.69%-24.98%-8.43% 155B
+3.84%+1.42%-6.93%-4.67% 103B
+3.85%+1.83%+3.41%+60.90% 57.7B
-0.34%+0.06%+36.33%+53.27% 52.27B
+3.26%+6.02%-10.29%-38.34% 42.68B
+4.23%+0.64% - - 33.35B
+7.22%+6.79%-7.31%-43.21% 28.06B
+0.96%+1.34%+61.53%-5.89% 25.36B
-0.85%+4.34%-3.58%-18.66% 21.03B
Average +2.34%+3.02%+6.02%-0.63% 57.66B
Weighted average by Cap. +5.32%+2.97%-3.42%+2.30%

Financials

2024 2025
Net sales 12.29M 14.06M 11.37M 10.43M 19.74M 1.36B 20.09M 136M 53.26M 662M 52.81M 51.65M 2.28B 12.8M 14.65M 11.84M 10.87M 20.56M 1.41B 20.92M 141M 55.47M 689M 55.01M 53.8M 2.38B
Net income -3.63M -4.15M -3.36M -3.08M -5.83M -400M -5.93M -40.04M -15.73M -195M -15.6M -15.25M -675M -2.58M -2.96M -2.39M -2.19M -4.15M -285M -4.22M -28.51M -11.2M -139M -11.11M -10.86M -480M
Net Debt -1.1M -1.26M -1.02M -934K -1.77M -121M -1.8M -12.14M -4.77M -59.27M -4.73M -4.63M -205M -314K -359K -290K -266K -504K -34.61M -513K -3.46M -1.36M -16.9M -1.35M -1.32M -58.36M
Logo aap Implantate AG
aap Implantate AG is a Germany-based provider of medical devices for human muscular and skeletal systems. The Company focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . It also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The Company operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
Employees
-